39 results
Here is a quick guide on the common direct-acting antivirals (DAAs) for chronic hepatitis C virus
Antivirals #table #treatment ... #hcv #medications ... #infectiousdisease ... HepatitisC #Management #Pharmacology
Mechanism of Action for Common Diabetes Medications

 • SGLT2i (Dapagliflozin)
 • TZD (Pioglitazone)
 • Biguanides (Metformin)
Common Diabetes Medications ... Meglitinides • GLP-1 ... #Diabetes #Medications ... #pharmacology # ... pathophysiology
Migraine Treatment Overview

 • What is a Migraine?
 • Pathophysiology
 • Common Migraine Triggers
 • Diagnosis
Migraine Treatment ... • Pathophysiology ... Common Migraine Triggers ... Prophylactic Treatment ... #management #pharmacology
Adjuvant therapies in critical care: steroids to treat infectious diseases
 - Severe Community Acquired Pneumonia
Corticosteroids #Adjuvant #InfectiousDiseases ... #Infections #Pharmacology ... #Management #Treatment ... #Indications
Uric Acid Homeostasis
In the liver, purines are metabolized to uric acid. The last step in purine
eliminate about 1/ ... Homeostasis #Gout #Pathophysiology ... #Pharmacology # ... Medications #Management
Neurological Side Effects of Antipsychotic Drugs
Acute dystonia - Spasm of muscles of tongue, face, neck, back
back • Time: 1- ... reduction; change medication ... months or years of treatment ... months or years of treatment ... #SideEffects #pharmacology
Long-Acting Injectable (LAI) - Atypical Antipsychotics 
INVEGA TRINZA 3 MONTHS 
ARISTADA 2 MONTHS 
INVEGA 1 MONTH
SUSTENNA
MONTHS INVEGA 1 ... MONTH ABILIFY 1 ... are used in the treatment ... Adherence to daily medications ... Antipsychotics #Pharmacology
ED Opioid Stewardship Algorithm

Opioid Naive vs Opioid Tolerant

1. Patient Specific, Pain Syndrome-Targeted Approach
2. Combinations of Non-Pharmacologic
Opioid Tolerant 1. ... Combinations of Non-Pharmacologic ... Medication Assisted ... Treatment (MAT)
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
screen within 1 ... 0.5mL IM at 0, 1– ... IDSA #Prevention #Treatment ... #management #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
4–6 mL QID or 1– ... for effective treatment ... IDSA #Prevention #Treatment ... #management #opportunistic ... infections #HIVAIDS #pharmacology